化学
化学型
组蛋白脱乙酰基酶
立体化学
催化作用
表征(材料科学)
组蛋白
分子模型
计算化学
生物化学
纳米技术
基因
材料科学
色谱法
精油
作者
Olasunkanmi O. Olaoye,Paris R. Watson,Nabanita Nawar,Mulu Geletu,Abootaleb Sedighi,Shazreh Bukhari,Yasir S. Raouf,Pimyupa Manaswiyoungkul,Fettah Erdogan,Ayah Abdeldayem,Aaron D. Cabral,Muhammad Murtaza Hassan,Krimo Toutah,Andrew E. Shouksmith,Justyna M. Gawel,Johan Israelian,Tudor B. Radu,Niyati Kachhiyapatel,Elvin D. de Araujo,David W. Christianson
标识
DOI:10.1021/acs.jmedchem.0c01922
摘要
Histone deacetylase 6 (HDAC6) is involved in multiple regulatory processes, ranging from cellular stress to intracellular transport. Inhibition of aberrant HDAC6 activity in several cancers and neurological diseases has been shown to be efficacious in both preclinical and clinical studies. While selective HDAC6 targeting has been pursued as an alternative to pan-HDAC drugs, identifying truly selective molecular templates has not been trivial. Herein, we report a structure–activity relationship study yielding TO-317, which potently binds HDAC6 catalytic domain 2 ( K i = 0.7 nM) and inhibits the enzyme function (IC 50 = 2 nM). TO-317 exhibits 158-fold selectivity for HDAC6 over other HDAC isozymes by binding the catalytic Zn 2+ and, uniquely, making a never seen before direct hydrogen bond with the Zn 2+ coordinating residue, His614. This novel structural motif targeting the second-sphere His614 interaction, observed in a 1.84 Å resolution crystal structure with dr HDAC6 from zebrafish, can provide new pharmacophores for identifying enthalpically driven, high-affinity, HDAC6-selective inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI